The corner office is getting repriced: $1 salaries, 20M-share option bets, same-day exits

The $1 salary is back

Copart's board approved a grant of 20 million stock options to CEO A. Jayson Adair, split into four tranches of 5 million shares each with exercise prices of $26.27, $35.03, $43.78 and $52.54, the filing says. The grant is subject to stockholder approval at the 2026 annual meeting or a later special meeting. For the 10 years after the grant date, Adair is expected to receive a salary of $1 a year and no bonus or additional equity awards — this grant is the compensation. m:…6896

The structure is all patience and clawback. The options vest and become exercisable on the fifth anniversary of the grant date, and the vested shares are subject to a 10 percent annual clawback for each year of the 10-year term after Adair's service as CEO ends. If a change in control arrives first, unvested options whose change-in-control price exceeds the exercise price vest immediately before the deal. m:…6896

The transition package

Builders FirstSource shows the same board instinct in a transition package. Its compensation committee approved a new arrangement for Mike Hiller on October 14, 2026: a $675,000 base salary effective January 1, 2027, an annual bonus target of 125 percent of salary, and time-based restricted stock units worth $700,000 granted October 18, 2026. Outgoing executive Steve Herron stays on as special advisor from January 1 through March 31, 2027, at $20,833.34 a month — a paid handoff. m:…8566

This reads as a board buying continuity rather than speed. The incoming executive's pay is set in October 2026 but does not take effect until January 1, 2027, and the outgoing executive stays on a three-month paid advisory leash ending March 31, 2027 — a quarter of overlap at $20,833.34 a month. The filing discloses no drama, just arithmetic: new pay on a future start date, old hands paid to linger through the handoff. m:…8566

Same-week exits

Not every corner office is being repriced; some are being vacated. Ocular Therapeutix disclosed that Sanjay Nayak notified the company on October 14, 2026 that he was resigning as chief officer effective October 16, 2026 — two days later — to become the chief officer of a privately-held company. m:…2509

LifeStance Health Group disclosed that director Teresa DeLuca notified the board on October 14, 2026 that she is resigning from the board and all its committees effective December 31, 2026. The filing states the resignation is not the result of any disagreement between DeLuca and the company. m:…1515

What the pattern suggests

This suggests boards are treating senior-leader retention as a pricing problem rather than a salary problem. The Copart package pays essentially nothing for a decade unless the stock performs, and Builders FirstSource times its new pay to a future start date while paying the outgoing executive to stay through the handoff. The structures concentrate pay in the future rather than the present — equity and timing instead of cash. m:…6896 m:…8566

The two departures are the other side of the same ledger. When retention is priced in cliffs and tranches, the people who do not stay leave quickly: Nayak walked out two days after notifying, and DeLuca gave notice on the same October 14 while scheduling her exit for year-end. A banker reading this week's filings sees boards willing to write big equity checks to the leaders they keep, and no visible effort to stop the ones leaving. m:…2509 m:…1515